Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 6.


Alhassan, Yussif, Twimukye, Adelline, Malaba, Thoko, Orrell, Catherine, Myer, Landon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Lamorde, Mohammed, Kambugu, Andrew, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye
et al (show 1 more authors) (2020) Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda. BMC Public Health, 20 (1). 1883-.


Alhassan, Yussif, Twimukye, Adelline, Malaba, Thoko, Orrell, Catherine, Myer, Landon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Lamorde, Mohammed, Kambugu, Andrew, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye
et al (show 1 more authors) (2020) Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda. BMC HEALTH SERVICES RESEARCH, 20 (1). 705-.


Hakim, James G, Thompson, Jennifer, Kityo, Cissy, Hoppe, Anne, Kambugu, Andrew, van Oosterhout, Joep J, Lugemwa, Abbas, Siika, Abraham, Mwebaze, Raymond, Mweemba, Aggrey
et al (show 7 more authors) (2017) Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. The Lancet. Infectious diseases, 18 (1). pp. 47-57.


Ahmad, Raheelah, Atun, Rifat A, Birgand, Gabriel, Castro-Sanchez, Enrique, Charani, Esmita ORCID: 0000-0002-5938-1202, Ferlie, Ewan B, Hussain, Izhar, Kambugu, Andrew, Labarca, Jaime, Hara, Gabriel Levy
et al (show 7 more authors) (2021) Macro level influences on strategic responses to the COVID-19 pandemic - an international survey and tool for national assessments. JOURNAL OF GLOBAL HEALTH, 11. 05011-.


Paton, Nicholas I, Kityo, Cissy, Thompson, Jennifer, Nankya, Immaculate, Bagenda, Leonard, Hoppe, Anne, Hakim, James, Kambugu, Andrew, van Oosterhout, Joep J, Kiconco, Mary
et al (show 5 more authors) (2017) Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial. The lancet. HIV, 4 (8). e341-e348.


Charani, Esmita ORCID: 0000-0002-5938-1202, McKee, Martin, Ahmad, Raheelah, Balasegaram, Manica, Bonaconsa, Candice, Merrett, Gemma Buckland, Busse, Reinhard, Carter, Vanessa, Castro-Sanchez, Enrique, Franklin, Bryony D
et al (show 18 more authors) (2021) Optimising antimicrobial use in humans-review of current evidence and an interdisciplinary consensus on key priorities for research. LANCET REGIONAL HEALTH-EUROPE, 7. 100161-.

This list was generated on Sun Apr 7 00:53:06 2024 BST.